Details

Autor(en) / Beteiligte

• Bousquet, Philippe Jean
• Lefeuvre, Delphine
• Tuppin, Philippe
• BenDiane, Marc Karim
• Rocchi, Mathieu
• Bouée-Benhamiche, Elsa
• Viguier, Jérôme
• Le Bihan-Benjamin, Christine
• Stepkowski, Stanislaw

Titel

Cancer care and public health policy evaluations in France: Usefulness of the national cancer cohort

Ist Teil von

• PloS one, 2018-10, Vol.13 (10), p.e0206448-e0206448

Ort / Verlag

United States: Public Library of Science

Erscheinungsjahr

2018

Quelle

MEDLINE

Beschreibungen/Notizen

• In the context of the national Cancer Plans of France that have changed the healthcare landscape, it has become necessary to better document and assess the related actions, and to promote research and understanding. The national cancer cohort, an exhaustive population-based cohort, was set up on the basis of the National Health Data System (SNDS) by the French National Cancer Institute. The aim is to describe the French national cancer cohort. All people living in France (67 million population) with universal insurance coverage and diagnosed, treated or followed up for a cancer, such as survivors, are included and will be followed up for 25 years. It contains all healthcare consumptions and reimbursements (i.e. hospitalization, outpatient care, medication…) since 2010. Every year, around 650 000 new cases are included. From 2010 to 2015, 6.2 million subjects have been included. Most subjects were entered in 2010, in 2015 it concerned 0.6 million. In 2015, the median age was 65 [54-76]; 51% were women. The primary cancer organ could be attributed with certitude to 87% of the people. The most frequent locations were skin (16%), breast (15%), prostate (12%), colon-rectum (11%) and lung (9%). In 2015, 40% of included subjects underwent surgery for cancer, 16% chemotherapy at hospital and 11% at least one session of radiotherapy. Based on SNDS, the cancer cohort has been designed to study cancer care use in the short-, medium- and long-term, and evaluate healthcare and public health policies.